
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Smoking cessation presents unique challenges for marginalized groups who often lack access to tailored support. Consequently, a recent pilot study evaluated the EQQUAL program as a specialized SGM smoking cessation intervention. Specifically, this avatar-led digital health program utilizes Acceptance and Commitment Therapy (ACT) to help sexual and gender minority (SGM) young adults quit smoking.
Researchers recruited 124 participants aged 18 to 30 for this randomized controlled pilot trial. The team divided the cohort into two groups to compare EQQUAL with the standard Smokefree.gov program. Both interventions provided users with a web application and integrated text messaging services. After three months, the team assessed smoking abstinence through biochemical verification.
Results indicated that EQQUAL users experienced significantly higher rates of biochemically-verified abstinence. Specifically, 11.1% of the EQQUAL arm remained abstinent compared to only 4.9% in the control group. Moreover, participants reported higher overall satisfaction scores and usability ratings with the tailored digital interface. However, the study found that users only completed an average of 1.4 out of 6 digital sessions.
Furthermore, the theory-based change processes did not show robust differences between the two study arms. This suggests that while the tailored content improves immediate abstinence, the mechanism of change requires further investigation. Therefore, clinicians suggest that increasing user engagement might further improve these promising cessation outcomes. This specialized SGM smoking cessation intervention represents a vital step toward reducing health disparities in tobacco use.
Culturally-tailored digital tools offer a scalable solution for high-risk populations. Clinicians should consider such tools to support diverse patient populations effectively, especially those who may avoid traditional healthcare settings due to stigma. While initial results are positive, practitioners should emphasize the importance of completing all digital sessions to maximize the program's benefits.
The EQQUAL program is specifically tailored for sexual and gender minority young adults. It uses an avatar-led interface and Acceptance and Commitment Therapy (ACT) to address the unique psychosocial stressors and barriers this population faces when quitting smoking.
In the pilot trial, the EQQUAL group achieved a biochemically-verified abstinence rate of 11.1%. In contrast, the control group using the Smokefree.gov program achieved a rate of only 4.9%.
Despite higher satisfaction, user engagement remained low, with participants completing an average of only 1.4 out of 6 sessions. Researchers believe that increasing this engagement is key to further improving cessation outcomes.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

A randomized pilot trial evaluates EQQUAL, a digital health tool for SGM young adult smoking cessation, showing promising results over standard programs....
2 weeks back

A study in Yasuj highlights how Health Belief Model-based education significantly improves PPE compliance and worker safety attitudes in industrial settings...
Today

A study indicates severe endometriosis patients have lower liver fat accumulation, suggesting estrogen-linked protection against steatotic liver disease....
Today

An umbrella review confirms that ultra-processed food consumption significantly raises risks for obesity, T2DM, CVD, and mental health disorders globally....
Today

A systematic review finds insufficient evidence to link lower-limb length discrepancy to curve progression in adolescent idiopathic scoliosis (AIS)....
Today

A new study identifies Glut1 and Cirl receptors as key regulators of huntingtin protein aggregation during aging, linking metabolism to neurodegeneration....
Today